In this issue:
Community pharmacists as catalysts for deprescribing
Continuation of ORT delivery after cyclones in Queensland
Men’s views on antidepressant treatment
Patient-designed 3D-printed medicine
Some ED visits could potentially be managed by pharmacists
Impact of restricting tobacco sales to pharmacies
Perceptions of treatment risk in benzodiazepine users
Bedtime antihypertensive dosing improves cardiovascular risk reduction
Is ward round participation by clinical pharmacists worthwhile?
Community pharmacist-led medication review procedures in Europe
Please login below to download this issue (PDF)